PhD ceremony: Ms. W.Y. Yuen, 12.45 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Junctional epidermolysis bullosa
Promotor(s): prof. M.F. Jonkman, prof. R.J. Sinke
Faculty: Medical Sciences
They are called "Butterfly Children", the patients with epidermolysis bullosa (EB) with a skin as fragile as the wings of a butterfly. Approximately 25 distinct types of EB have been identified, which are caused by mutations in one of the 15 genes that are known to be involved. Junctional epidermolysis bullosa (JEB) is an EB type characterized by a cleavage through the junctional layer between the epidermis and dermis. The adhesion proteins in the junctional layer are disturbed or absent.
In the subtype JEB, type Herlitz (JEB-H) laminin-332 is totally absent. Children with JEB-H do not grow and suffer from painful erosions on their entire skin and in their throat. JEB-H is associated with hopeless, unbearable suffering and is fatal within the first 3 years of life. Twenty-two children with JEB-H were guided by the Center for Blistering Diseases in the UMCG from 1988 to 2011. This thesis presents the diagnostic features and long-term follow-up of these patients. We also interviewed parents who had lost their child to lethal EB, on which we based guidelines for the guidance of future parents. In one of the children, the parents asked for euthanasia, which was performed according to the Groningen protocol.
Another part of this thesis focuses on the less severe subtype JEB, type non-Herlitz (JEB-nH), in which patients do survive to adulthood. We showed that adult JEB-nH patients have -from an early age on- an increased risk (25%) of developing an aggressive squamous cell carcinoma that metastasizes in 20% of the patients. Another study describes that punch grafting, in which small skin grafts are placed in chronic wounds to promote wound healing, is an easy and effective treatment in JEB-nH patients. Furthermore, we show that JEB of late onset is caused by mutations in the gene COL17A1.
Vandaag opent het UMCG de Groningen Microbioom Hub: een nieuwe faciliteit met state-of-the-art technologie waarin alle UMCG-expertise op het gebied van microbioomonderzoek samenkomt. Dit zorgt voor unieke mogelijkheden in onderzoek en maakt nieuwe...
Science often seems very complicated. Most people probably don't really know what researchers do, and what it takes to make a breakthrough. That is why it is important to keep the general public informed of what is happening in science, says Iris...
Het UMCG zet kunstmatige intelligentie (artificial intelligence, afgekort AI) in om zorgverleners te helpen bij het beantwoorden van schriftelijke vragen van patiënten. Dit gebeurt in samenwerking met andere ziekenhuizen vanuit de EPIC Nederlandse...
The UG website uses functional and anonymous analytics cookies. Please answer the question of whether you want to accept
or reject other cookies (such as tracking cookies).
If no choice is made, only basic cookies will be stored. More information